Dr. Xiaobin Wu

Dr. Xiaobin Wu

President and Chief Operating OfficeratBeOne Medicines· In proxies 2021–2025

Pay in FY2025+8% from the year before · BeOne Medicines stock +64.5% the same year

Dr. Xiaobin Wu was paid $12.0M in FY2025 (Dec), up 8%. BeOne Medicines stock rose 64.5% that year.

Pay$100 in the stock at the end of FY20 → $118
Pay is from the Summary Compensation Table of each BeOne Medicines proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. BeOne MedicinesPublic company · 5 yr
    • President and Chief Operating Officer2021 – Present · 5 yrStock in role +42%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?